Kachuri, Linda http://orcid.org/0000-0002-3226-4727
Hoffmann, Thomas J. http://orcid.org/0000-0001-6893-4449
Jiang, Yu
Berndt, Sonja I.
Shelley, John P.
Schaffer, Kerry R.
Machiela, Mitchell J. http://orcid.org/0000-0001-6538-9705
Freedman, Neal D.
Huang, Wen-Yi http://orcid.org/0000-0002-4440-3368
Li, Shengchao A.
Easterlin, Ryder
Goodman, Phyllis J.
Till, Cathee
Thompson, Ian
Lilja, Hans http://orcid.org/0000-0001-5871-7846
Van Den Eeden, Stephen K.
Chanock, Stephen J. http://orcid.org/0000-0002-2324-3393
Haiman, Christopher A.
Conti, David V.
Klein, Robert J. http://orcid.org/0000-0003-3539-5391
Mosley, Jonathan D. http://orcid.org/0000-0001-6421-2887
Graff, Rebecca E. http://orcid.org/0000-0003-0316-8303
Witte, John S. http://orcid.org/0000-0003-0146-1434
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA241410, K99CA246076, P30CA008748, P50CA92629, R01CA175491, R01CA244948)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM130791)
Article History
Received: 14 March 2022
Accepted: 27 February 2023
First Online: 1 June 2023
Competing interests
: J.S.W. is a non-employee cofounder of Avail Bio. H.L. is named on a patent for intact PSA assays and a patent for a statistical method to detect prostate cancer that is licensed to and commercialized by OPKO Health. H.L. receives royalties from sales of the test and has stock in OPKO Health. All other authors have no competing interests.